Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R S Ungerleider

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Cancer Treatment Reports|July 1, 1981
Working conference on neuroblastoma treatment trialsR S Ungerleider
Cancer Treatment Reviews|December 1, 1980
Antitumor activity of chlorozotocin (NSC-178748)R S Ungerleider
Journal of the National Cancer Institute|January 2, 1991
Sex, trials, and datatapesR S Ungerleider, M A Friedman
Oncology (Williston Park, N.Y.)|March 1, 1993
Clinical trials referral resourceB D Cheson, R S Ungerleider
Oncology (Williston Park, N.Y.)|October 1, 1992
Clinical trials referral resource. High Priority TrialsB D Cheson, R S Ungerleider
Oncology (Williston Park, N.Y.)|November 1, 1992
Clinical trials referral resourceB D Cheson, R S Ungerleider
Oncology (Williston Park, N.Y.)|December 1, 1992
Clinical trials referral resource. High priority trials--III. Breast cancerB D Cheson, R S Ungerleider
Journal of the National Cancer Institute|November 20, 1996
Assessing whether to perform a confirmatory randomized clinical trialM K Parmar, R S Ungerleider, R Simon
Medical and Pediatric Oncology|January 1, 1994
Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risksM A Smith, L Rubinstein, R S Ungerleider
Cancer Research|January 1, 1982
Pediatric cancer and nutrition workshop: introductory commentsR S Ungerleider, W D DeWys, D J Fink
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Cancer Treatment Reports|July 1, 1981
Working conference on neuroblastoma treatment trialsR S Ungerleider
Cancer Treatment Reviews|December 1, 1980
Antitumor activity of chlorozotocin (NSC-178748)R S Ungerleider
Journal of the National Cancer Institute|January 2, 1991
Sex, trials, and datatapesR S Ungerleider, M A Friedman
Oncology (Williston Park, N.Y.)|March 1, 1993
Clinical trials referral resourceB D Cheson, R S Ungerleider
Oncology (Williston Park, N.Y.)|October 1, 1992
Clinical trials referral resource. High Priority TrialsB D Cheson, R S Ungerleider
Oncology (Williston Park, N.Y.)|November 1, 1992
Clinical trials referral resourceB D Cheson, R S Ungerleider
Oncology (Williston Park, N.Y.)|December 1, 1992
Clinical trials referral resource. High priority trials--III. Breast cancerB D Cheson, R S Ungerleider
Journal of the National Cancer Institute|November 20, 1996
Assessing whether to perform a confirmatory randomized clinical trialM K Parmar, R S Ungerleider, R Simon
Medical and Pediatric Oncology|January 1, 1994
Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risksM A Smith, L Rubinstein, R S Ungerleider
Cancer Research|January 1, 1982
Pediatric cancer and nutrition workshop: introductory commentsR S Ungerleider, W D DeWys, D J Fink
Pageof 3